Cart
sales@molnova.com
PLX-5622
CAS No. 1303420-67-8
PLX-5622( —— )
Catalog No. M20529 CAS No. 1303420-67-8
PLX-5622 is a highly selective brain penetrant and oral active CSF1R inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 70 | In Stock |
|
| 5MG | 74 | In Stock |
|
| 10MG | 121 | In Stock |
|
| 25MG | 242 | In Stock |
|
| 50MG | 398 | In Stock |
|
| 100MG | 518 | In Stock |
|
| 200MG | 734 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePLX-5622
-
NoteResearch use only, not for human use.
-
Brief DescriptionPLX-5622 is a highly selective brain penetrant and oral active CSF1R inhibitor.
-
DescriptionPLX-5622 is a highly selective brain penetrant and oral active CSF1R inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayTyrosine Kinase
-
TargetCSF1R
-
RecptorCSF-1R
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1303420-67-8
-
Formula Weight395.41
-
Molecular FormulaC21H19F2N5O
-
Purity>98% (HPLC)
-
SolubilityDMSO:79 mg/mL (199.79 mM)
-
SMILESCOc1ncc(F)cc1CNc1ccc(Cc2c[nH]c3ncc(C)cc23)c(F)n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Rosin JM Vora SR Kurrasch DM.Depletion of embryonic microglia using the CSF1R inhibitor PLX5622 has adverse sex-specific effects on mice including accelerated weight gain hyperactivity and anxiolytic-like behaviour[J].Brain Behav Immun. 2018 Oct;73:682-697.
molnova catalog
related products
-
c-Fms-IN-13
c-Fms-IN-13 (compound 14) is a potent FMS kinase inhibitor (IC50 = 17 nM) and serves as an anti-inflammatory agent.
-
ARRY-382
ARRY-382 is a highly selective oral inhibitor of CSF-1R with an IC50 of 9 nM.
-
Emactuzumab
Emactuzumab(RG 7155) is a monoclonal antibody against colony-stimulating factor-1 receptor targeting tumor-associated macrophages (TAMs) Emactuzumab has antitumor activity and inhibits activation of colony-stimulating factor 1 receptor (CSF1R) Emactuzumab has a high affinity for CSF-1R with a Ki value of 0.2 nM.
